title: Canadian paediatricians' opinions on rotavirus vaccination.
abstract: Rotavirus is the leading cause of dehydration and hospitalization due to gastroenteritis (GE) in young children. Almost all children are affected by the age of 5 years. Two safe and effective rotavirus vaccines are available for clinical use in Canada. In the context where rotavirus vaccination is recommended, but not publicly funded, we have assessed paediatricians' knowledge, attitudes and beliefs (KAB) regarding rotavirus disease and its prevention by vaccination. A self-administered anonymous questionnaire based upon the Health Belief Model and the Analytical framework for immunization programs was mailed to all 1852 Canadian paediatricians. The response rate was 50%. The majority of respondents rated consequences of rotavirus infection for young patients as moderate. Sixty-six percent considered that rotavirus disease occur frequently without vaccination and 62% estimated that the disease generates a significant economic burden. Sixty-nine percent of respondents considered rotavirus vaccines to be safe and 61%, to be effective. The reduction of severe GE cases was seen as the main benefit of rotavirus vaccination, while the risk of adverse events was the principal perceived barrier. Fifty-three percent (53%) indicated a strong intention to recommend rotavirus vaccines. In multivariate analysis, main determinant of paediatricians' intention to recommend rotavirus vaccines was the perceived health and economic burden of rotavirus diseases (partial R(2)=0.49, p<0.0001). More than half of surveyed paediatricians were willing to recommend rotavirus vaccines to their patients, but the proportion of respondents who had a strong intention to do so remains low when compared to several other new vaccines. As with other new vaccines, rotavirus vaccine uptake risks to remain low in Canada as long as it is not publicly funded.
authors.affiliation: Institut national de santé publique du Québec, 2400 d'Estimauville, Québec, Québec, Canada. eve.dube@ssss.gouv.qc.ca
authors.forename: E
authors.initials: E
authors.lastname: Dubé
authors.forename: V
authors.initials: V
authors.lastname: Gilca
authors.forename: C
authors.initials: C
authors.lastname: Sauvageau
authors.forename: R
authors.initials: R
authors.lastname: Bradet
authors.forename: J A
authors.initials: JA
authors.lastname: Bettinger
authors.forename: N
authors.initials: N
authors.lastname: Boulianne
authors.forename: F D
authors.initials: FD
authors.lastname: Boucher
authors.forename: S
authors.initials: S
authors.lastname: McNeil
authors.forename: I
authors.initials: I
authors.lastname: Gemmill
authors.forename: F
authors.initials: F
authors.lastname: Lavoie
mesh_terms: D001291:Attitude of Health Personnel; D002170:Canada; D002675:Child, Preschool; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D012400:Rotavirus Infections / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D022243:Rotavirus Vaccines